unilad homepage
unilad homepage
  • News
    • UK News
    • US News
    • World News
    • Crime
    • Health
    • Money
    • Sport
    • Travel
  • Music
  • Technology
  • Film and TV
    • News
    • DC Comics
    • Disney
    • Marvel
    • Netflix
  • Celebrity
  • Politics
  • Advertise
  • Terms
  • Privacy & Cookies
  • LADbible Group
  • LADbible
  • SPORTbible
  • GAMINGbible
  • Tyla
  • UNILAD Tech
  • FOODbible
  • License Our Content
  • About Us & Contact
  • Jobs
  • Latest
  • Archive
  • Topics A-Z
  • Authors
Facebook
Instagram
X
Threads
TikTok
YouTube
Submit Your Content
New study reveals what really happens to people’s bodies when they stop taking weight loss drugs
Home>News>Health
Published 20:42 8 Jan 2026 GMT

New study reveals what really happens to people’s bodies when they stop taking weight loss drugs

Weight loss injections have become all the rage but a new study has explored whether they help you to keep the pounds off in the long-run

William Morgan

William Morgan

google discoverFollow us on Google Discover
Featured Image Credit: Getty Stock Images

Topics: Weight loss, Mounjaro, Health

William Morgan
William Morgan

Advert

Advert

Advert

The results of a massive study examining the health outcomes of people taking weight loss medications has found out what really happens to your body when you stop taking the injections.

These GLP-1 agonist injections, which include brand names like Wegovy and Mounjaro, have helped millions of people to lose a considerable amount of body mass, becoming an integral tool in the fight against obesity.

They work by mimicking the glucagon-like peptide 1 hormone that helps you to regulate when and how much you eat, taking away the desire to eat more than you need that makes it so hard for many people to follow a diet plan.

But Oxford University researchers, who created a study examining GLP-1 drugs and the medical results of 9,341 patients from 37 other studies, have found that this stunning weight loss might only be temporary.

Advert

The pounds start piling on quick once patients stop using weight loss jabs (Getty Stock Image)
The pounds start piling on quick once patients stop using weight loss jabs (Getty Stock Image)

Publishing their findings in the British Medical Journal, the researchers found that patients dropped about a fifth of their total weight during a typical 39-week course of treatment, which would be an incredible result for a normal weight loss program.

However, once patients stopped receiving their GLP-1 medications, they found that many would regain a considerable amount of weight without the hunger-regulating effects of the GLP-1 drugs.

Oxford researcher Dr Susan Jebb warned: "People buying these need to be aware of the risk of fast weight regain when the treatment ends."

On average, patients would regain 0.8kg (1.7lbs) per months, meaning that they returned to their pre-jab weight in just a year and a half.

This is a much more rapid weight gain than people who follow a normal diet plan and discontinue, which saw a monthly gain of 0.1kg (0.22lbs).

This rapid weight gain was not a result of the GLP-1 injections, but rather a lack of behavioral change from patients receiving the drugs, a researcher explained.

Following a proper diet and making lifestyle changes is still the best way to lose weight and keep it gone (Getty Stock Image)
Following a proper diet and making lifestyle changes is still the best way to lose weight and keep it gone (Getty Stock Image)

Oxford's Dr Sam West said: “These medicines are transforming obesity treatment and can achieve important weight loss. However, our research shows that people tend to regain weight rapidly after stopping - faster than we see with behavioural programs."

While the research showed that many were rapidly regaining their lost weight, it did not mean that these new treatments are not effective.

He added: “This isn’t a failing of the medicines – it reflects the nature of obesity as a chronic, relapsing condition.

"It sounds a cautionary note for short-term use without a more comprehensive approach to long-term weight management, and highlights the importance of primary prevention.”

Other studies have indicated that these GLP-1 drugs can have a positive impact on a number of health metrics beside weight, with benefits for your brain and cardiovascular health.

But another finding of the study was that some of these observable health benefits also return to normal after a short period. Like with weight, they found that positive blood pressure and cholesterol biomarkers faded after 1.4 years.

Choose your content:

3 hours ago
4 hours ago
6 hours ago
7 hours ago
  • Leonardo Munoz / AFP
    3 hours ago

    E. Jean Carroll breaks silence with savage message after Donald Trump officially pays her $5.6 million damages

    The author trolled Trump's legal team on social media after a federal judge ordered the immediate release of the cash.

    News
  • Aaron Schwartz/Bloomberg via Getty Images
    4 hours ago

    Lindsey Graham's sister delivers emotional message after being sworn into his Senate seat

    Darline Graham made history as South Carolina’s first female senator in a deeply emotional Washington ceremony

    News
  • Photo by: Arterra/Universal Images Group via Getty Images
    6 hours ago

    Officials warn of giant jellyfish with 120 foot tentacles as they swarm US beaches

    The jellies have been found in Maine, Cape Cod, and beyond New England shores

    News
  • Paul Weaver/SOPA Images/LightRocket via Getty Images
    7 hours ago

    Federal investigators now probing Taco Bell over outbreak of parasite that causes ‘explosive diarrhea’

    More than 80 people have been hospitalized as a result of the parasite outbreak

    News
  • Doctors explain why some develop 'Ozempic feet' after taking weight loss drugs
  • New study reveals record number of Americans are now using GLP-1 weight loss drugs
  • Doctor explains the dangers of children using GLP-1s as parents turn to weight loss drugs
  • Expert issues urgent health warning after man dies taking unapproved weight loss drug 'Reta'